Need reconstitution solution? Don't forget to add Bacteriostatic Water — available as a quick add in your cart before checkout.
Dual GH Secretagogue Blend
Two Pathways, One Goal: Synergistic Growth Hormone Research
This blend combines CJC-1295 (No DAC) and Ipamorelin — two peptides that stimulate growth hormone release through distinct but complementary mechanisms. CJC-1295 acts on GHRH receptors while Ipamorelin targets the ghrelin/GHS receptor. Together, they produce synergistic effects that exceed either peptide alone, making this blend essential for comprehensive GH axis research.
- 10mg total: CJC-1295 (5mg) + Ipamorelin (5mg)
- Dual-pathway GH stimulation (GHRH + Ghrelin receptors)
- Synergistic effects when combined
- Preserves natural pulsatile GH secretion patterns
- No DAC formulation for controlled research protocols
For laboratory research use only. Not for human consumption.
Complementary Mechanisms
How Two Peptides Amplify Growth Hormone Release
CJC-1295 stimulates GH release by binding to GHRH receptors on the pituitary — the same pathway used by the body's natural growth hormone-releasing hormone. Ipamorelin works through a completely different mechanism: it's a potent agonist of the ghrelin/GHS receptor, one of the most selective GH secretagogues known. This dual-receptor approach raises both baseline GH levels and peak secretion while maintaining natural pulsatile patterns.
- CJC-1295: GHRH receptor agonist (pituitary stimulation)
- Ipamorelin: Ghrelin/GHS receptor agonist (highly selective)
- Raises baseline GH levels (Ipamorelin effect)
- Produces higher peaks and troughs (CJC-1295 effect)
- Maintains natural pulsatile secretion pattern
For laboratory research use only. Not for human consumption.
Research Applications
From Bone Health to Metabolic Function — Comprehensive GH Research
The CJC-1295/Ipamorelin combination enables research across the full spectrum of GH-mediated effects. Ipamorelin alone has demonstrated benefits for bone health, muscle development, insulin release, and gastric function in animal models. Combined with CJC-1295's ability to normalize growth in GHRH-deficient models, this blend provides a comprehensive platform for GH axis research.
- Bone health and mineral density research
- Muscle repair and development studies
- Insulin secretion and metabolic function
- Bowel motility and gastric function research
- Body composition and lean mass studies
- GH axis dysfunction and restoration modeling
For laboratory research use only. Not for human consumption.
The Science Behind Dual-Pathway GH Stimulation: Why This Combination Works
The CJC-1295/Ipamorelin blend represents a strategic approach to growth hormone research — combining two peptides that work through completely different receptor systems to produce synergistic effects. This dual-pathway design achieves what neither peptide can accomplish alone.
CJC-1295 (No DAC) is a modified GHRH analog that stimulates the pituitary's growth hormone-releasing hormone receptors. Research demonstrates it normalizes growth in GHRH knockout models and preserves natural pulsatile GH secretion even during continuous stimulation. The "No DAC" formulation (without Drug Affinity Complex) provides shorter-acting effects ideal for controlled research protocols.
Ipamorelin is among the most selective GH secretagogues ever developed — a potent ghrelin/GHS receptor agonist with minimal effects on cortisol, prolactin, or other hormones. Studies have shown it improves bone mineral content, counteracts glucocorticoid-induced bone loss, stimulates pancreatic insulin release, and enhances gastric motility in postoperative ileus models.
When combined, these peptides create a "higher set point" for GH secretion. Ipamorelin raises baseline levels such that CJC-1295 produces both higher peaks and higher troughs — all while maintaining the natural ebb and flow of pulsatile secretion. For research teams investigating GH axis function, bone metabolism, body composition, or metabolic regulation, this blend provides enhanced effects without substantially increased complexity.
For research use only. Not for human consumption.
Scientific References
- Teichman SL, et al. Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults. J Clin Endocrinol Metab. 2006;91(3):799-805.
- Ionescu M, Frohman LA. Pulsatile secretion of growth hormone (GH) persists during continuous stimulation by CJC-1295, a long-acting GH-releasing hormone analog. J Clin Endocrinol Metab. 2006;91(12):4792-4797.
- Raun K, et al. Ipamorelin, the first selective growth hormone secretagogue. Eur J Endocrinol. 1998;139(5):552-561.
- Svensson J, et al. The GH secretagogues ipamorelin and GH-releasing peptide-6 increase bone mineral content in adult female rats. J Endocrinol. 2000;165(3):569-577.
- Andersen NB, et al. The growth hormone secretagogue ipamorelin counteracts glucocorticoid-induced decrease in bone formation of adult rats. Growth Horm IGF Res. 2001;11(5):266-272.
CERTIFICATE
A detailed summary of the analytical profile, purity, and molecular integrity of the research-grade peptide compound.
Each vial contains a highly purified lyophilized peptide, produced under sterile laboratory conditions and tested for >99% purity via HPLC and mass spectrometry.
Formulated without additives or fillers, our peptides are ideal for cutting-edge scientific research in areas such as cellular mechanisms, tissue regeneration, and metabolic modulation.
For research use only. Not intended for human or veterinary use.
Each batch undergoes rigorous third-party testing to ensure molecular accuracy, sterility, and stability. Our commitment to scientific precision guarantees that every vial reflects the highest standards of quality control and consistency, making them ideal for reproducible and reliable research outcomes.
DIRECTIONS
All peptides are supplied in lyophilized powder form for research use only. Not intended for human or veterinary use.
Use Bacteriostatic Water (0.9%).
Slowly inject the liquid along the inner wall of the vial using a sterile syringe.
Do not shake. Swirl gently until the powder dissolves completely.
Recommended volume depends on your lab protocol (commonly 1–2 mL).
- : Keep lyophilized peptide at 36–46°F, or frozen (-4°F) for long-term stability.
- : Store in the refrigerator (36–46°F) and use within 10 to 30 days, depending on the peptide.
These compounds are intended for Research Use Only.
Always wear gloves and sterile lab gear.
Avoid contamination. Use clean tools and surfaces.
Dispose of all biological materials, including syringes and empty vials, according to your local laboratory safety regulations.
COMPOSITION
An overview of the research characteristics and integrity of the peptide compound.
Each vial contains a highly purified lyophilized peptide, produced under sterile laboratory conditions and tested for >99% purity via HPLC and mass spectrometry.
Formulated without additives or fillers, our peptides are ideal for cutting-edge scientific research in areas such as cellular mechanisms, tissue regeneration, and metabolic modulation.
For research use only. Not intended for human or veterinary use.
Each batch undergoes rigorous third-party testing to ensure molecular accuracy, sterility, and stability. Our commitment to scientific precision guarantees that every vial reflects the highest standards of quality control and consistency, making them ideal for reproducible and reliable research outcomes.
Peptides are shipped as lyophilized powder to ensure maximum stability. Upon arrival, store at -4°F in a dry, dark environment. Once reconstituted, use promptly or refrigerate at 36–46°F for short-term stability. Proper storage preserves biological integrity and ensures reliable research performance over time.
- Company
- Price
- Purity
- Quantity
- Shipping
-
Tirzepatide – 30mg
-
Peptidic.Peptide Sciences
-
$108.00$275.00
- ≥99.784%98–99.3%
- 30 mg15 mg
- Free 2-Day Shipping3-10 Business Day
-
